147 related articles for article (PubMed ID: 12166113)
1. [Nine-year's follow up on the appearance of autoantibodies in a child with idiopathic thrombocytopenic purpura subsequently developing lupus with central nervous system manifestations].
Kagitani M; Makino S; Kinjo Y; Hirano S; Tabushi Y; Sasaki M; Takeuchi T; Hanafusa T; Murata T
Ryumachi; 2002 Jun; 42(3):591-6. PubMed ID: 12166113
[TBL] [Abstract][Full Text] [Related]
2. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
[TBL] [Abstract][Full Text] [Related]
4. [Idiopathic thrombocytopenic purpura as first manifestation of systemic lupus erythematosus lupus].
Balsalobre Aznar J; Herráez Herrera P; Porta Etessam J; Torres Martín C; Bermell Serrano JC; Núñez López R; Mateo Bernardo I; Padrino Martínez JM; Morillas López L
An Med Interna; 1999 Dec; 16(12):611-4. PubMed ID: 10686711
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.
Pratt EL; Tarantino MD; Wagner D; Hirsch Pescovitz O; Bowyer S; Shapiro AD
Am J Hematol; 2005 Jul; 79(3):175-9. PubMed ID: 15981229
[TBL] [Abstract][Full Text] [Related]
7. [A recovered case of SLE with central nervous system involvement who relapsed presenting new symptoms associated with development of serum anti-Sm antibody].
Hiura K; Abe T; Hatanaka Y; Ikeda Y; Akaike J; Hosokawa A; Itoh Y; Takagi H; Sakai H; Suwa T; Yonezawa K; Tosaka M; Chiba S; Imai K
Ryumachi; 1998 Feb; 38(1):39-44. PubMed ID: 9564777
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura.
Zimmerman SA; Ware RE
J Pediatr Hematol Oncol; 1997; 19(4):297-303. PubMed ID: 9256827
[TBL] [Abstract][Full Text] [Related]
9. [Disseminated lupus erythematosus without antinuclear antibodies or other autoantibodies].
Duc J; Perroulaz G; Golaz J; Campiche M; Pécoud A
Schweiz Med Wochenschr; 1987 Feb; 117(6):205-8. PubMed ID: 3494306
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
11. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
Abbasi SY; Milhem M; Zaru L
Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983
[TBL] [Abstract][Full Text] [Related]
12. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset.
Vantelon JM; Godeau B; André C; Bierling P
Thromb Haemost; 2000 Jan; 83(1):42-5. PubMed ID: 10669152
[TBL] [Abstract][Full Text] [Related]
13. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
Faria AC; Barcellos KS; Andrade LE
J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
[TBL] [Abstract][Full Text] [Related]
15. Anti-beta2-glycoprotein I in childhood immune thrombocytopenic purpura.
El-Bostany EA; El-Ghoroury EA; El-Ghafar EA
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):26-31. PubMed ID: 18180612
[TBL] [Abstract][Full Text] [Related]
16. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
17. [Study of autoimmunity in progeny of pregnant women with systemic lupus erythematosus].
Tong X; Pan W; Hong S
Zhonghua Fu Chan Ke Za Zhi; 1999 Mar; 34(3):143-6. PubMed ID: 11263182
[TBL] [Abstract][Full Text] [Related]
18. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
[TBL] [Abstract][Full Text] [Related]
20. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
